… prophylactic efficacy of the vaccine for cervical, … vaccine efficacy observed in FUTURE-I
and FUTURE-II, the independent data and safety monitoring board recommended vaccination of …

… terms: (genital warts or genital wart or anogenital warts or … 17 have received all recommended
vaccine doses, rates that … , it is the only routinely recommended vaccine not required for …

… Risk of genital warts among girls vaccinated against human papillomavirus types 6, 11, 16,
… first vaccination and initiation of time to counting of genital wart cases for vaccinated girls). …

… It is generally recommended that quadrivalent HPV vaccine be administered from 9 years of
… of quadrivalent HPV vaccine in preventing genital cancer and warts following administration …

… HPV-11, responsible for 90% of genital warts. These vaccines have now been licensed by
the … Both vaccines are highly immunogenic and induce an immune response in up to 100% of …

… Genital warts (GW) are a common sexually transmitted disease in young people usually …
age groups following the introduction of prophylactic vaccines containing HPVs 6 and 11 virus-…

… National vaccine recommendations have not … vaccine if (1) it prevented all HPV, (2) it
prevented cervical cancer in women but did not prevent genital warts, (3) it prevented genital warts …

… vaccine HPV types in young women. Studies using the qHPV vaccine have shown a consistent
decrease in genital warts … not recommended that pregnant women receive the vaccines. …

… cervical cancer (>70% in all geographic areas), followed by 31, 33, 35, 45, 52, and 58; in
the group of low-risk HPV, types 6 and 11 are responsible for more than 90% of genital warts. …

… Recommendation: The treatment of warts using salicylic acid … It has also been debated
whether vaccination might also … evidence that vaccination with the vaccines currently approved …